Streptococcus pneumoniae as a Cause of Community-Acquired Pneumonia in Indian Adolescents and Adults: A Systematic Review and Meta-Analysis

被引:20
作者
Ghia, Canna J. [1 ]
Dhar, Raja [2 ]
Koul, Parvaiz A. [3 ]
Rambhad, Gautam [1 ]
Fletcher, Mark A. [4 ]
机构
[1] Pfizer Ltd, Med & Sci Affairs, Mumbai, Maharashtra, India
[2] Fortis Hosp, Dept Pulmonol, Kolkata, India
[3] Sher & Kashmir Inst Med Sci, Dept Internal & Pulm Med, Srinagar, Jammu & Kashmir, India
[4] Pfizer Inc, Emerging Markets Med, Paris, France
关键词
Community-acquired pneumonia; Streptococcus pneumoniae; bacterial pneumonia; pneumonia; aetiology; BACTERIOLOGICAL PROFILE; LEGIONELLA-PNEUMOPHILA; ETIOLOGY; MANAGEMENT; MORTALITY;
D O I
10.1177/1179548419862790
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
BACKGROUND: Streptococcus pneumoniae is one of the primary cause of community-acquired pneumonia (CAP) worldwide. However. scant data are available on the prevalence of etiological organisms for CAP in adolescent and adult Indian population. OBJECTIVE: We performed a systematic review and meta-analysis to determine the contribution of S. pneumoniae in the causation of CAP in Indian patients aged 12 years or above. METHODOLOGY: We performed a systematic search of both indexed and non-indexed publications using PubMed, databases of National Institute of Science Communication and Information Resources (NISCAIR), Annotated Bibliography of Indian Medicine (ABIM), Google Scholar, and hand search including cross-references using key terms community acquired pneumonia AND India'. All studies, published between January 1990 and January 2017 : that evaluated Indian patients aged above 12 years with a confirmed diagnosis of CAP were eligible for inclusion. Our search retrieved a total of 182 studies. of which only 17 and 12 qualified for inclusion in the systematic review of all etiological organisms, and meta-analysis of S. pneumonia, respectively. RESULTS: A total of 1435 patients met the inclusion criteria. The pooled proportion of patients with S. pneumoniae infection was 19% (95% confidence interval [CI]: 12%-26%; I-2 = 94.5% where I(2 )represents heterogeneity, P < .01), Other major etiological agents are Mycoplasma pneumoniae (15.5% [1.1%-35.5%]). Klebsiella pneumoniae (10.5% [1.6%-24.0%]), and Legionella pneumophila (7.3% [2.5%-23.8%]). CONCLUSIONS: Analysis found approximately a one-fifth proportion of adult Indian patients of CAP with S. pneumoniae infection, suggesting it as a leading organism for causing CAP compared with other etiological organisms.
引用
收藏
页数:9
相关论文
共 40 条
[1]   Microbiological Profile and Drug Sensitivity Pattern among Community Acquired Pneumonia Patients in Tertiary Care Centre in Mangalore, Coastal Karnataka, India [J].
Acharya, Vishak K. ;
Padyana, Mahesha ;
Unnikrishnan, B. ;
Anand, R. ;
Acharya, Preethm R. ;
Juneja, Divya Jyoti .
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2014, 8 (06) :MC4-MC6
[2]  
Anbumani S, 2010, INDIAN J MED RES, V131, P761
[3]  
ANDREWS BE, 1987, Q J MED, V62, P195
[4]   Application of real-time quantitative polymerase chain reaction assay to detect Legionella pneumophila in patients of community-acquired pneumonia in a tertiary care hospital [J].
Angrup, A. ;
Chaudhry, R. ;
Sharma, S. ;
Valavane, A. ;
Passi, K. ;
Padmaja, K. ;
Javed, S. ;
Dey, A. B. ;
Dhawan, B. ;
Kabra, S. K. .
INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2016, 34 (04) :539-543
[5]  
Bansal S, 2004, Indian J Chest Dis Allied Sci, V46, P17
[6]  
Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954
[7]   Polysaccharide Conjugate Vaccine against Pneumococcal Pneumonia in Adults [J].
Bonten, M. J. M. ;
Huijts, S. M. ;
Bolkenbaas, M. ;
Webber, C. ;
Patterson, S. ;
Gault, S. ;
van Werkhoven, C. H. ;
van Deursen, A. M. M. ;
Sanders, E. A. M. ;
Verheij, T. J. M. ;
Patton, M. ;
McDonough, A. ;
Moradoghli-Haftvani, A. ;
Smith, H. ;
Mellelieu, T. ;
Pride, M. W. ;
Crowther, G. ;
Schmoele-Thoma, B. ;
Scott, D. A. ;
Jansen, K. U. ;
Lobatto, R. ;
Oosterman, B. ;
Visser, N. ;
Caspers, E. ;
Smorenburg, A. ;
Emini, E. A. ;
Gruber, W. C. ;
Grobbee, D. E. .
NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (12) :1114-1125
[8]   METAANALYSIS IN CLINICAL-TRIALS [J].
DERSIMONIAN, R ;
LAIRD, N .
CONTROLLED CLINICAL TRIALS, 1986, 7 (03) :177-188
[9]  
Dey AB, 2000, NATL MED J INDIA, V13, P66
[10]  
Dey AB, 1997, NATL MED J INDIA, V10, P169